Ning Li

30PUBLICATIONS

54CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Planning and decision making

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jul 09, 2026

Addressing challenges in treating rare tumours: the strategy of China's National Cancer Center.

|Jul 06, 2026

Safety and feasibility of 5T4 antibody-coupled allogeneic NK cell therapy for solid tumors: a first-in-human phase 1 trial.

|May 28, 2026

Intrathecal Allogeneic B7-H3-targeted CAR γδ T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunological Dynamics in a Phase 1 Trial.

|May 15, 2026

Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasion.

|Mar 11, 2026

Target trial emulation in oncology: current use and future directions.

Hui-Yao Huang, Le Wang, Sheng Xu

|Feb 11, 2026

Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen, Iurie Bulat, Marina Maglakelidze

Pageof 5

Frequent Collaborators

Yale Jiang

Yuan Fang

Wei Guo

Yuan Li

Fei Ma

Kun Chen

Qi Lei

Andy Qingan Yuan

Yingjie Nie

Ning Jiang

Frequent Collaborators

Yale Jiang

Yuan Fang

Wei Guo

Yuan Li